4//SEC Filing
Heffernan Michael Thomas 4
Accession 0001062993-22-024501
CIK 0001267565other
Filed
Dec 26, 7:00 PM ET
Accepted
Dec 27, 7:17 PM ET
Size
24.1 KB
Accession
0001062993-22-024501
Insider Transaction Report
Form 4
Heffernan Michael Thomas
Director
Transactions
- Exercise/Conversion
Common Stock
2022-12-22$16.15/sh+237$3,828→ 28,260 total - Exercise/Conversion
Common Stock
2022-12-23$16.15/sh+4,989$80,572→ 33,012 total - Sale
Common Stock
2022-12-27$24.16/sh−3,820$92,291→ 28,023 total - Sale
Common Stock
2022-12-23$23.00/sh−4,989$114,747→ 28,023 total - Exercise/Conversion
Common Stock
2022-12-27$16.15/sh+15,995$258,319→ 44,018 total - Exercise/Conversion
Stock Option (Right to Purchase)
2022-12-22−237→ 24,804 totalExercise: $16.15Exp: 2026-01-20→ Common Stock (237 underlying) - Exercise/Conversion
Stock Option (Right to Purchase)
2022-12-23−4,989→ 19,815 totalExercise: $16.15Exp: 2026-01-20→ Common Stock (4,989 underlying) - Exercise/Conversion
Stock Option (Right to Purchase)
2022-12-27−15,995→ 3,820 totalExercise: $16.15Exp: 2026-01-20→ Common Stock (15,995 underlying) - Sale
Common Stock
2022-12-27$23.63/sh−15,995$377,962→ 28,023 total - Sale
Common Stock
2022-12-22$23.00/sh−237$5,451→ 28,023 total - Exercise/Conversion
Common Stock
2022-12-27$16.15/sh+3,820$61,693→ 31,843 total - Exercise/Conversion
Stock Option (Right to Purchase)
2022-12-27−3,820→ 0 totalExercise: $16.15Exp: 2026-01-20→ Common Stock (3,820 underlying)
Footnotes (5)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2022.
- [F2]The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.00 to $23.03, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2).
- [F3]The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.00 to $23.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3).
- [F4]The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.00 to $24.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4).
- [F5]The option, initially representing a right to purchase a total of 109,005 shares, is fully vested and exercisable.
Issuer
COLLEGIUM PHARMACEUTICAL, INC
CIK 0001267565
Entity typeother
Related Parties
1- filerCIK 0001448914
Filing Metadata
- Form type
- 4
- Filed
- Dec 26, 7:00 PM ET
- Accepted
- Dec 27, 7:17 PM ET
- Size
- 24.1 KB